🇺🇸 FDA
Patent

US 11020383

Methods for the treatment of cancer metastasis

granted A61KA61K31/407A61K31/445

Quick answer

US patent 11020383 (Methods for the treatment of cancer metastasis) held by The Board of Regents of the University of Texas System expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/407, A61K31/445, A61K31/454, A61K38/05